{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:34:26Z","timestamp":1761676466160,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003447","name":"State Scholarships Foundation","doi-asserted-by":"publisher","award":["SR229145"],"award-info":[{"award-number":["SR229145"]}],"id":[{"id":"10.13039\/501100003447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00198-016-3807-0","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T19:58:42Z","timestamp":1479412722000},"page":"991-999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Increased CD14+ and decreased CD14\u2212 populations of monocytes 48\u00a0h after zolendronic acid infusion in breast cancer patients"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-0309","authenticated-orcid":false,"given":"A.","family":"Kyrgidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Yavropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lagoudaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Andreadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Antoniades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kouvelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"key":"3807_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"3807_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bihy.2009.02.005","volume":"2","author":"A Kyrgidis","year":"2009","unstructured":"Kyrgidis A, Triaridis S, Antoniades K (2009) Effects of bisphosphonates on keratinocytes and fibroblasts may have a role in the development of osteonecrosis of the jaw. Biosci Hypotheses 2:153\u2013159","journal-title":"Biosci Hypotheses"},{"key":"3807_CR3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1586\/era.09.74","volume":"9","author":"A Kyrgidis","year":"2009","unstructured":"Kyrgidis A, Triaridis S, Vahtsevanos K, Antoniades K (2009) Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Expert Rev Anticancer Ther 9:1125\u20131134","journal-title":"Expert Rev Anticancer Ther"},{"key":"3807_CR4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12974\/2311-8695.2015.03.02.4","volume":"3","author":"A Kyrgidis","year":"2015","unstructured":"Kyrgidis A, Yavropoulou M, Tilaveridis I, Andreadis C, Antoniades K, Kouvelas D (2015) A systematic review of bone anti-resorptive treatment toxicity in innate and adaptive immunity cells: osteonecrosis of the jaws and future implications. J Dentists 3:50\u201359","journal-title":"J Dentists"},{"key":"3807_CR5","doi-asserted-by":"crossref","unstructured":"Kyrgidis A, Tzellos T-G, Toulis K, Antoniades K (2011) The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications. Journal of Osteoporosis 2011:Article ID 147689, 147610 pages, doi:147610.144061\/142011\/147689","DOI":"10.4061\/2011\/147689"},{"key":"3807_CR6","first-page":"CD002010","volume":"3","author":"LS Conwell","year":"2014","unstructured":"Conwell LS, Chang AB (2014) Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database of Syst Rev 3:CD002010","journal-title":"Cochrane Database of Syst Rev"},{"key":"3807_CR7","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.amjcard.2014.03.008","volume":"113","author":"A Sharma","year":"2014","unstructured":"Sharma A, Einstein AJ, Vallakati A, Arbab-Zadeh A, Walker MD, Mukherjee D, Homel P, Borer JS, Lichstein E (2014) Risk of atrial fibrillation with use of oral and intravenous bisphosphonates. Am J Cardiol 113:1815\u20131821","journal-title":"Am J Cardiol"},{"key":"3807_CR8","first-page":"1131","volume":"25","author":"SH Lee","year":"2013","unstructured":"Lee SH, Chang SS, Lee M, Chan RC, Lee CC (2013) Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis. Osteoporos Int 25:1131\u20131139","journal-title":"Osteoporos Int"},{"key":"3807_CR9","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","volume":"26","author":"A Kyrgidis","year":"2008","unstructured":"Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z, Patrikidou A, Triaridis S (2008) Biphosphonate related osteonecrosis of the jaws: risk factors in breast cancer patients. A case control study. J Clin Oncol 26:4634\u20134638","journal-title":"J Clin Oncol"},{"key":"3807_CR10","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E et al (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27:5356\u20135362","journal-title":"J Clin Oncol"},{"issue":"475\u2013483","key":"3807_CR11","first-page":"e473","volume":"121","author":"LM Hess","year":"2008","unstructured":"Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2008) Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121(475\u2013483):e473","journal-title":"Am J Med"},{"key":"3807_CR12","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","volume":"26","author":"A Badros","year":"2008","unstructured":"Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E, Zervas K, Baer MR, Meiller T, Dimopoulos MA (2008) Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 26:5904\u20135909","journal-title":"J Clin Oncol"},{"key":"3807_CR13","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jbmr.2525","volume":"30","author":"S Otto","year":"2015","unstructured":"Otto S, Marx RE, Tr\u00f6ltzsch M et al (2015) Comments on \u201cdiagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus\u201d. J Bone Miner Res 30:1113\u20131115","journal-title":"J Bone Miner Res"},{"key":"3807_CR14","doi-asserted-by":"crossref","unstructured":"Cardona F, Bag\u00e1n JV, S\u00e1inz E, Figuerido J, Giner F, Vid\u00e1n FJ (2009) Osteonecrosis de los maxilares por bisfosfonatos: Actualizaci\u00f3n y puesta al d\u00eda. Anales del Sistema Sanitario de Navarra 32","DOI":"10.4321\/S1137-66272009000500012"},{"key":"3807_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2014","unstructured":"Khan AA, Morrison A, Hanley DA et al (2014) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"3807_CR16","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.joms.2009.06.021","volume":"67","author":"A Kyrgidis","year":"2009","unstructured":"Kyrgidis A (2009) Novel hypotheses in the etiopathogenesis of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67:2554","journal-title":"J Oral Maxillofac Surg"},{"key":"3807_CR17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","volume":"94","author":"H Katsarelis","year":"2015","unstructured":"Katsarelis H, Shah NP, Dhariwal DK, Pazianas M (2015) Infection and medication-related osteonecrosis of the jaw. J Dent Res 94:534\u2013539","journal-title":"J Dent Res"},{"key":"3807_CR18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jnci\/djq516","volume":"103","author":"M Pazianas","year":"2011","unstructured":"Pazianas M (2011) Osteonecrosis of the jaw and the role of macrophages. J Natl Cancer Inst 103:232\u2013240","journal-title":"J Natl Cancer Inst"},{"key":"3807_CR19","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2741\/3388","volume":"14","author":"S Reuter","year":"2009","unstructured":"Reuter S, Lang D (2009) Life span of monocytes and platelets: importance of interactions. Front Biosci (Landmark Edition) 14:2432\u20132447","journal-title":"Front Biosci (Landmark Edition)"},{"key":"3807_CR20","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/IAI.69.6.3772-3781.2001","volume":"69","author":"DP Funda","year":"2001","unstructured":"Funda DP, Tuckova L, Farre MA, Iwase T, Moro I, Tlaskalova-Hogenova H (2001) CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect Immun 69:3772\u20133781","journal-title":"Infect Immun"},{"key":"3807_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0167-5699(93)90212-4","volume":"14","author":"HW Ziegler-Heitbrock","year":"1993","unstructured":"Ziegler-Heitbrock HW, Ulevitch RJ (1993) CD14: cell surface receptor and differentiation marker. Immunol Today 14:121\u2013125","journal-title":"Immunol Today"},{"key":"3807_CR22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1440-1711.2005.01370.x","volume":"83","author":"HPA Jersmann","year":"2005","unstructured":"Jersmann HPA (2005) Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol Cell Biol 83:462\u2013467","journal-title":"Immunol Cell Biol"},{"key":"3807_CR23","first-page":"329","volume":"3","author":"F Zamani","year":"2013","unstructured":"Zamani F, Zare Shahneh F, Aghebati-Maleki L, Baradaran B (2013) Induction of CD14 expression and differentiation to monocytes or mature macrophages in Promyelocytic cell lines: new approach. Adv Pharm Bull 3:329\u2013332","journal-title":"Adv Pharm Bull"},{"key":"3807_CR24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00784-014-1273-7","volume":"19","author":"S Hoefert","year":"2015","unstructured":"Hoefert S, Schmitz I, Weichert F, Gaspar M, Eufinger H (2015) Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases. Clin Oral Investig 19:497\u2013508","journal-title":"Clin Oral Investig"},{"key":"3807_CR25","doi-asserted-by":"crossref","unstructured":"Marcu-Malina V, Balbir-Gurman A, Dardik R, Braun-Moscovici Y, Segel M, Bank I (2014) A novel prothrombotic pathway in systemic sclerosis patients: possible role of bisphosphonate activated \u03b3\u03b4 T cells. Front Immunol:5","DOI":"10.3389\/fimmu.2014.00414"},{"key":"3807_CR26","unstructured":"Biosciences B (2010) Human and mouse CD marker handbook. Becton, Dickinson and Company., San Jose, CA 95131"},{"key":"3807_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/1074-7613(95)90164-7","volume":"3","author":"S Lecoanet-Henchoz","year":"1995","unstructured":"Lecoanet-Henchoz S, Gauchat J-F, Aubry J-P et al (1995) CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3:119\u2013125","journal-title":"Immunity"},{"key":"3807_CR28","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.4049\/jimmunol.155.10.4868","volume":"155","author":"M Armant","year":"1995","unstructured":"Armant M, Rubio M, Delespesse G, Sarfati M (1995) Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J Immunol 155:4868\u20134875","journal-title":"J Immunol"},{"key":"3807_CR29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","volume":"208","author":"V Bigley","year":"2011","unstructured":"Bigley V, Haniffa M, Doulatov S et al (2011) The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208:227\u2013234","journal-title":"J Exp Med"},{"key":"3807_CR30","doi-asserted-by":"crossref","unstructured":"Roberts AW, He S, Ritchie D, Hertzberg MS, Kerridge I (2010) A phase I study of anti-CD123 monoclonal antibody (CD123) CSL360 targeting leukemia stem cells (LSC) in AML. J Clin Oncol 28","DOI":"10.1200\/jco.2010.28.15_suppl.e13012"},{"key":"3807_CR31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaci.2004.05.038","volume":"114","author":"N Novak","year":"2004","unstructured":"Novak N, Allam JP, Hagemann T, Jenneck C, Laffer S, Valenta R, Kochan J, Bieber T (2004) Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 114:364\u2013370","journal-title":"J Allergy Clin Immunol"},{"key":"3807_CR32","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.humimm.2003.08.342","volume":"64","author":"Y Ueda","year":"2003","unstructured":"Ueda Y, Hagihara M, Okamoto A, Higuchi A, Tanabe A, Hirabayashi K, Izumi S, Makino T, Kato S, Hotta T (2003) Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum Immunol 64:1144\u20131151","journal-title":"Hum Immunol"},{"key":"3807_CR33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2141.1995.tb05195.x","volume":"90","author":"H Strobl","year":"1995","unstructured":"Strobl H, Scheinecker C, Csmarits B, Majdic O, Knapp W (1995) Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis. Br J Haematol 90:774\u2013782","journal-title":"Br J Haematol"},{"key":"3807_CR34","doi-asserted-by":"crossref","unstructured":"Gill S, Tasian S, Ruella M et al (2013) Anti-CD123 chimeric antigen receptor T cells (CART-123) provide a novel myeloablative conditioning regimen that eradicates human acute myeloid leukemia in preclinical models. Blood 122","DOI":"10.1182\/blood.V122.21.143.143"},{"key":"3807_CR35","doi-asserted-by":"crossref","unstructured":"Mardiros A, Dos Santos C, McDonald T, et al (2013) T cells expressing CD123-specific cytolytic effector functions and anti-tumor effects against human acute myeloid leukemia. Blood.","DOI":"10.1182\/blood-2012-12-474056"},{"key":"3807_CR36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-3083.2007.02051.x","volume":"67","author":"J Skrzeczynska-Moncznik","year":"2008","unstructured":"Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J (2008) Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 67:152\u2013159","journal-title":"Scand J Immunol"},{"key":"3807_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00223-013-9750-6","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Adami S, Viapiana O, Tripi G, Zanotti R, Ortolani R, Vella A, Troplini S, Gatti D (2013) Acute phase response after zoledronic acid is associated with long-term effects on white blood cells. Calcif Tissue Int 93:249\u2013252","journal-title":"Calcif Tissue Int"},{"key":"3807_CR38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","volume":"144","author":"AJ Roelofs","year":"2009","unstructured":"Roelofs AJ, Jauhiainen M, Monkkonen H, Rogers MJ, Monkkonen J, Thompson K (2009) Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP. Br J Haematol 144:245\u2013250","journal-title":"Br J Haematol"},{"key":"3807_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4419-1050-9_2","volume":"658","author":"K Thompson","year":"2010","unstructured":"Thompson K, Roelofs AJ, Jauhiainen M, Monkkonen H, Monkkonen J, Rogers MJ (2010) Activation of gammadelta T cells by bisphosphonates. Adv Exp Med Biol 658:11\u201320","journal-title":"Adv Exp Med Biol"},{"key":"3807_CR40","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jbmr.1769","volume":"28","author":"S Kalyan","year":"2013","unstructured":"Kalyan S, Quabius ES, Wiltfang J, Monig H, Kabelitz D (2013) Can peripheral blood gammadelta T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy. J Bone Miner Res 28:728\u2013735","journal-title":"J Bone Miner Res"},{"key":"3807_CR41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bone.2009.09.026","volume":"46","author":"A Kyrgidis","year":"2010","unstructured":"Kyrgidis A, Verrou E (2010) Fatigue in bone: a novel phenomenon attributable to bisphosphonate use. Bone 46:556","journal-title":"Bone"},{"key":"3807_CR42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0029-1224109","volume":"41","author":"AD Anastasilakis","year":"2009","unstructured":"Anastasilakis AD, Toulis KA, Goulis DG, Polyzos SA, Delaroudis S, Giomisi A, Terpos E (2009) Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis. Horm Metab Res 41:721\u2013729","journal-title":"Horm Metab Res"},{"key":"3807_CR43","first-page":"2113","volume":"7","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Chen C, Zhang J, Ji X, Liu L, Zhang G, Cao X, Wang P (2014) Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis. Int J Clin Exp Pathol 7:2113\u20132122","journal-title":"Int J Clin Exp Pathol"},{"key":"3807_CR44","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/art.39075","volume":"67","author":"JR Curtis","year":"2015","unstructured":"Curtis JR, Xie F, Yun H, Saag KG, Chen L, Delzell E (2015) Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab. Arthritis & Rheumatology 67:1456\u20131464","journal-title":"Arthritis & Rheumatology"},{"key":"3807_CR45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1601-0825.2011.01848.x","volume":"18","author":"X Ji","year":"2012","unstructured":"Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D (2012) Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis 18:85\u201395","journal-title":"Oral Dis"},{"key":"3807_CR46","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.179.3.1449","volume":"179","author":"S Iwamoto","year":"2007","unstructured":"Iwamoto S, Iwai S, Tsujiyama K, Kurahashi C, Takeshita K, Naoe M, Masunaga A, Ogawa Y, Oguchi K, Miyazaki A (2007) TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses. J Immunol (Baltimore, Md : 1950) 179:1449\u20131457","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"3807_CR47","doi-asserted-by":"crossref","first-page":"117.110","DOI":"10.4049\/jimmunol.188.Supp.117.10","volume":"188","author":"S Tundup","year":"2012","unstructured":"Tundup S, Srivastava L, Nagy T, Harn D (2012) CD14 deficiency enhances Th2 responses and alternative activation of macrophages in response to schistosome infection or IL-4. (117.10). The. J Immunol 188:117.110","journal-title":"J Immunol"},{"key":"3807_CR48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V28.3.455.455","volume":"28","author":"DM WHITELAW","year":"1966","unstructured":"WHITELAW DM, Bell M (1966) The intravascular lifespan of monocytes. Blood 28:455\u2013464","journal-title":"Blood"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3807-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3807-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3807-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T23:39:34Z","timestamp":1692574774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3807-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3807"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3807-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2016,11,17]]}}}